These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2656368)
1. Arbaprostil [15(R)-15-methyl prostaglandin E2] in a single nighttime dose of either 50 or 100 micrograms in acute duodenal ulcer. Euler AR; Bailey RJ; Zinny MA; Brandon ML; Rousseau B; Ferguson JP; Wood DR; Le VH Gastroenterology; 1989 Jul; 97(1):98-103. PubMed ID: 2656368 [TBL] [Abstract][Full Text] [Related]
2. A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer. Euler AR; Popiela T; Tytgat GN; Kulig J; Lookabaugh JL; Phan TD; Kitt MM Gastroenterology; 1989 Apr; 96(4):967-71. PubMed ID: 2647578 [TBL] [Abstract][Full Text] [Related]
3. Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study. Vantrappen G; Janssens J; Popiela T; Kulig J; Tytgat GN; Huibregtse K; Lambert R; Pauchard JP; Robert A Gastroenterology; 1982 Aug; 83(2):357-63. PubMed ID: 7044880 [TBL] [Abstract][Full Text] [Related]
4. Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers. Results of a multiclinic trial. Euler AR; Tytgat G; Berenguer J; Brunner H; Wood DR; Lookabaugh JL; Phan TD Gastroenterology; 1987 Mar; 92(3):604-7. PubMed ID: 3545965 [TBL] [Abstract][Full Text] [Related]
5. An evaluation of arbaprostil at multiple doses for the treatment of acute duodenal ulcer: a randomized double-blind placebo-controlled international trial. Euler AR; Krawiec J; Odes H; Gilat T; Garcia L; Rachmilewitz D; Gabryelewicz A; Gibinski K; Bass D; Barbara L Am J Gastroenterol; 1990 Feb; 85(2):145-9. PubMed ID: 2405642 [TBL] [Abstract][Full Text] [Related]
6. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups. Euler AR; Safdi M; Rao J; Jaszewski R; Welsh J; Le V; Raskin J; Fleischmann R; Razzaque M; Champion C Gastroenterology; 1990 Jun; 98(6):1549-57. PubMed ID: 2186951 [TBL] [Abstract][Full Text] [Related]
7. Failure of a cytoprotective dose of Arbacet to heal acute gastric ulcers. Jaszewski R; Crane SA Am J Gastroenterol; 1988 Jul; 83(7):734-6. PubMed ID: 3289379 [TBL] [Abstract][Full Text] [Related]
8. Cytoprotective doses of arbacet with minimal antisecretory properties are not effective in duodenal ulcer healing. Wengrower D; Fich A; Goldin E; Eliakim R; Ligumsky M; Rachmilewitz D Dig Dis Sci; 1987 Aug; 32(8):857-60. PubMed ID: 3608733 [TBL] [Abstract][Full Text] [Related]
9. Effect of prostaglandin E2 and 15(R)15 methyl PGE2 on duodenal ulcer. Chen FW; Leong RS; Ng PL; Karim SM Singapore Med J; 1980 Jun; 21(3):596-8. PubMed ID: 7003723 [No Abstract] [Full Text] [Related]
10. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study. Gilbert DA; Surawicz CM; Silverstein FE; Weinberg CR; Saunders DR; Feld AD; Sanford RL; Bergman D; Washington P Gastroenterology; 1984 Feb; 86(2):339-45. PubMed ID: 6360786 [TBL] [Abstract][Full Text] [Related]
11. Treatment of duodenal ulcer with enprostil, a synthetic prostaglandin E2 analogue. Thomson AB Am J Med; 1986 Aug; 81(2A):59-63. PubMed ID: 3092657 [TBL] [Abstract][Full Text] [Related]
12. The effect of 15(R)-15-methyl prostaglandin E2 (Arbacet) on the healing of aspirin or nonsteroidal antiinflammatory drug-induced gastric mucosal lesions: an endoscopic study. Jaszewski R; Crane SA Am J Gastroenterol; 1987 Dec; 82(12):1271-4. PubMed ID: 3318402 [TBL] [Abstract][Full Text] [Related]